EUVIMEDEUVIMED entdecken
Crossref

Hyperbaric oxygen therapy exerts anti‐osteoporotic effects in obese and lean D‐galactose‐induced aged rats

Napatsorn Imerb iD, Chanisa Thonusin iD, Wasana Pratchayasakul iD, Krittikan Chanpaisaeng iD, Ratchaneevan Aeimlapa iD, Narattaphol Charoenphandhu iD, Nipon Chattipakorn iD, Siriporn C Chattipakorn iD

The FASEB Journal · 2023

DOI: 10.1096/fj.202301197rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Napatsorn Imerb und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, Osteoporosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 96 Literaturangaben. Gefördert von: National Science and Technology Development Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity accelerates the aging processes, resulting in an aggravation of aging‐induced osteoporosis. We investigated the anti‐osteoporotic effect of hyperbaric oxygen therapy (HBOT) in obese‐ and lean‐aged rats through measurement of cellular senescence, hypoxia, inflammation, antioxidants, and bone microarchitecture. Obese and lean male Wistar rats were injected with 150 mg/kg/day of D‐galactose for 8 weeks to induce aging. Then, all rats were randomly given either sham or HBOT for 14 days. Metabolic parameters were determined. Expression by bone mRNA for cellular senescence, hypoxia, inflammation, antioxidative capacity, and bone remodeling were examined. Micro‐computed tomography and atomic absorption spectroscopy were performed to evaluate bone microarchitecture and bone mineral profiles, respectively. We found that HBOT restored the alterations in the mRNA expression level of p16, p21, HIF‐1α, TNF‐α, IL‐6, RANKL, RANK, NFATc1, DC–STAMP, Osx, ALP, and Col1a1 in the bone in obese‐and lean‐ aging rats. In obese‐aging rats, HBOT increased the level of expression of Sirt1 and CuZnSOD mRNA and diminished the expression level of HIF‐2α and ctsk mRNA to the same levels as the control group. However, HBOT failed to alter catalase and OCN mRNA expression in obese‐aged rats. HBOT partially improved the bone microarchitecture in obese‐aged rats, but completely restored it in lean‐aged rats. Interestingly, HBOT protected against obesity‐induced demineralization in obese‐aged rats. In summary, HBOT exerts an anti‐osteoporotic effect in lean‐aged rats and prevents some, but not all the negative effects of obese‐aged conditions on bone health. Therefore, HBOT is considered as a potential therapy for aging‐induced osteoporosis, regardless of obese status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperbaric OxygenationOsteoporosisRatsMaleAnimalsRats, WistarGalactoseX-Ray MicrotomographyObesityInflammationHypoxiaRNA, Messenger

Stichwörter der Autor:innen

D-galactoseHBOTagingobesityosteoporosis

Substanzen

GalactoseRNA, Messenger

Autor:innen und Institutionen

  • Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Center of Excellence in Cardiac Electrophysiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Chiang Mai University, Chiang Mai, Thailand.
  • Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • National Center for Genetic Engineering and Biotechnology (BIOTEC), Pathum Thani, Thailand.
  • Center of Calcium and Bone Research (COCAB), Faculty of Science, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Napatsorn Imerb, Chanisa Thonusin, Wasana Pratchayasakul, Krittikan Chanpaisaeng, Ratchaneevan Aeimlapa, Narattaphol Charoenphandhu, Nipon Chattipakorn, Siriporn C Chattipakorn

Förderung

  • National Science and Technology Development Agency

Zitieren

APA

Imerb, N., Thonusin, C., Pratchayasakul, W., Chanpaisaeng, K., Aeimlapa, R., Charoenphandhu, N., Chattipakorn, N., & Chattipakorn, S. C. (2023). Hyperbaric oxygen therapy exerts anti‐osteoporotic effects in obese and lean D‐galactose‐induced aged rats. The FASEB Journal. https://doi.org/10.1096/fj.202301197rr

Vancouver

Imerb N, Thonusin C, Pratchayasakul W, Chanpaisaeng K, Aeimlapa R, Charoenphandhu N, et al. Hyperbaric oxygen therapy exerts anti‐osteoporotic effects in obese and lean D‐galactose‐induced aged rats. The FASEB Journal. 2023. doi:10.1096/fj.202301197rr

BibTeX
@article{Imerb2023,
  author = {Imerb, Napatsorn and Thonusin, Chanisa and Pratchayasakul, Wasana and Chanpaisaeng, Krittikan and Aeimlapa, Ratchaneevan and Charoenphandhu, Narattaphol and Chattipakorn, Nipon and Chattipakorn, Siriporn C},
  title = {Hyperbaric oxygen therapy exerts anti‐osteoporotic effects in obese and lean D‐galactose‐induced aged rats},
  journal = {The FASEB Journal},
  year = {2023},
  doi = {10.1096/fj.202301197rr}
}
Kostenlos starten →